Reports for METHYLPHENIDATE HYDROCHLORIDE

Ingredient

METHYLPHENIDATE HYDROCHLORIDE

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
FOQUEST 85MG CAPSULE (CONTROLLED RELEASE) Resolved 2023-02-03 2023-02-17 183533
FOQUEST 85MG CAPSULE (CONTROLLED RELEASE) Resolved 2023-04-05 2023-04-19 188877
FOQUEST 85MG CAPSULE (CONTROLLED RELEASE) Resolved 2023-07-21 2023-08-28 199441
FOQUEST 85MG CAPSULE (CONTROLLED RELEASE) Resolved 2023-09-07 2023-09-23 203858
ACT METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2018-11-01 2024-02-13 65990
ACT METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2024-03-28 2024-05-09 223862
ACT METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2018-11-01 2024-02-13 65993
ACT METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2018-11-01 2024-02-13 65996
ACT METHYLPHENIDATE ER 54MG TABLET (EXTENDED-RELEASE) Resolved 2018-11-01 2024-02-13 65999
FOQUEST 25MG CAPSULE (CONTROLLED RELEASE) Resolved 2022-04-15 2022-04-23 158910

Showing 171 to 180 of 197

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
RITALIN-SR TAB 20MG 20MG TABLET (EXTENDED-RELEASE) Discontinued 2022-02-08 2022-04-05 154439
RITALIN 10MG 10MG TABLET Discontinued 2022-02-08 2022-05-11 154449
RITALIN 20MG 20MG TABLET Discontinued 2019-07-22 2019-08-01 89771
PMS-METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Discontinued 2020-06-17 2020-06-17 118105
PMS-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Discontinued 2020-06-17 2020-06-17 118099
PMS-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Discontinued 2020-06-17 2020-06-17 118108
PMS-METHYLPHENIDATE ER 54MG TABLET (EXTENDED-RELEASE) Discontinued 2020-06-17 2020-06-17 118102
SANDOZ METHYLPHENIDATE SR 20MG TABLET (EXTENDED-RELEASE) Discontinued 2022-05-24 2022-05-24 161221
METHYLPHENIDATE 5MG TABLET Discontinued 2019-04-10 2019-04-11 81132
METHYLPHENIDATE 10MG TABLET Discontinued 2019-04-10 2019-04-11 81136

Showing 1 to 10 of 11